日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of rimegepant for the acute treatment of migraine in Black or African American adults: A post hoc pooled subgroup analysis from three randomized, placebo-controlled clinical trials

利美吉泮治疗黑人或非裔美国成年人急性偏头痛的疗效和安全性:来自三项随机、安慰剂对照临床试验的事后汇总亚组分析

Charleston, Larry 4th; Armand, Cynthia E; Monteith, Teshamae S; O'Brien, Hope L; Abbott, Chandra C; Pixton, Glenn C; Fullerton, Terence

Safety of Rimegepant in Adults with Migraine and Anxiety, Depression, or Using Antidepressants: Analysis of a Multicenter, Long-Term, Open-Label Study

利美吉泮在患有偏头痛、焦虑症、抑郁症或正在服用抗抑郁药的成年患者中的安全性:一项多中心、长期、开放标签研究的分析

Kudrow, David; Hutchinson, Susan; Pixton, Glenn C; Fullerton, Terence

Hospitalization Following Outpatient Diagnosis of Respiratory Syncytial Virus in Adults

成人呼吸道合胞病毒门诊诊断后住院治疗

Landi, Suzanne N; Garofalo, Diana C; Reimbaeva, Maya; Scott, Amie M; Jiang, Lili; Cappell, Katherine; Lewandowski, David; Bonafede, Machaon; Brzozowski, Kaylen; Drebert, Zuzanna; Temple, Mike; Tawadrous, Margaret; Pixton, Glenn C; Alami, Niki; Kelly, Scott P; Aliabadi, Negar; Begier, Elizabeth; Swan, Joshua T

Long-Term Use of Rimegepant 75 mg for the Acute Treatment of Migraine is Associated with a Reduction in the Utilization of Select Analgesics and Antiemetics

长期使用瑞美吉泮75毫克治疗急性偏头痛与减少某些镇痛药和止吐药的使用有关。

Fullerton, Terence; Pixton, Glenn

Observed efficacy and clinically important improvements in participants with osteoarthritis treated with subcutaneous tanezumab: results from a 56-week randomized NSAID-controlled study

皮下注射他尼珠单抗治疗骨关节炎患者的疗效及临床显著改善:一项为期 56 周的随机非甾体抗炎药对照研究的结果

Neogi, Tuhina; Hunter, David J; Churchill, Melvin; Shirinsky, Ivan; White, Alexander; Guermazi, Ali; Omata, Masanari; Fountaine, Robert J; Pixton, Glenn; Viktrup, Lars; Brown, Mark T; West, Christine R; Verburg, Kenneth M

General Safety and Tolerability of Subcutaneous Tanezumab for Osteoarthritis: A Pooled Analysis of Three Randomized, Placebo-Controlled Trials

皮下注射他尼珠单抗治疗骨关节炎的总体安全性和耐受性:三项随机、安慰剂对照试验的汇总分析

Berenbaum, Francis; Schnitzer, Thomas J; Kivitz, Alan J; Viktrup, Lars; Hickman, Anne; Pixton, Glenn; Brown, Mark T; Davignon, Isabelle; West, Christine R

Efficacy, General Safety, and Joint Safety of Tanezumab in Japanese Patients with Osteoarthritis: Subgroup Analyses from Two Randomized, Phase 3 Studies

Tanezumab治疗日本骨关节炎患者的疗效、总体安全性和关节安全性:两项随机3期研究的亚组分析

Miki, Kenji; Ohta, Makoto; Abe, Manabu; Yoshimatsu, Hiroki; Fujii, Koichi; Ebata, Nozomi; West, Christine R; Brown, Mark T; Pixton, Glenn; Isogawa, Naoki

Uterine didelphys with dicavitary twin gestation: A case report

双子宫伴双腔双胎妊娠:病例报告

King, Alison Laura; Pixton, Sarah; Lanzarone, Valeria

A multicenter, primary-care-based, open-label study to assess the success of converting opioid-experienced patients with chronic moderate-to-severe pain to morphine sulfate and naltrexone hydrochloride extended-release capsules using a standardized conversion guide

一项多中心、以基层医疗机构为基础的开放标签研究,旨在评估使用标准化转换指南将既往使用过阿片类药物的慢性中重度疼痛患者转换为使用硫酸吗啡和盐酸纳曲酮缓释胶囊的成功率。

Setnik, Beatrice; Roland, Carl L; Sommerville, Kenneth W; Pixton, Glenn C; Berke, Robert; Calkins, Anne; Goli, Veeraindar

A multicenter, primary care-based, open-label study to identify behaviors related to prescription opioid misuse, abuse, and diversion in opioid-experienced patients with chronic moderate-to-severe pain

一项多中心、以初级保健为基础的开放标签研究,旨在识别有阿片类药物使用经验的慢性中重度疼痛患者中与处方阿片类药物误用、滥用和转移相关的行为。

Setnik, Beatrice; Roland, Carl L; Sommerville, Kenneth W; Pixton, Glenn C; Berke, Robert; Calkins, Anne; Goli, Veeraindar